[ Price : $8.95]
Merck reports that its Phase 3 TroFuse-005 trial evaluating the investigational antibody-drug conjugate sacituzumab tirumotecan me...[ Price : $8.95]
A legal analysis reviews how an FDA guidance issued last year is reshaping how pharmaceutical and medical device companies can com...[ Price : $8.95]
DTC Perspectives CEO Bob Ehrlich says the sudden departure of former FDA commissioner Marty Makary is unlikely to result in major ...[ Price : $8.95]
Two prominent drug-policy scholars sharply criticize former FDA commissioner Marty Makary in a Health Affairs commentary, arguing ...[ Price : $8.95]
FDA replaces the acting leaders of CDER and CBER following the resignation of former commissioner Marty Makary.[ Price : $8.95]
FDA approves AstraZenecas Baxfendy (baxdrostat), an aldosterone synthase inhibitor for adults with hypertension whose blood pressu...[ Price : $8.95]
FDA places a clinical hold on an Aardvark Therapeutics clinical trial on its experimental metabolic drug ARD-101 based on a cardia...[ Price : $8.95]
The U.S. Supreme Court temporarily preserves nationwide access to the abortion pill mifepristone by mail, blocking a lower court r...